Visit our alphabetical listing and map listing to browse them all. Know of others we can profile? Feel free to send us a list (and contacts if any).
What's new
We are happy to announce four new IQVIA profiles in our resource, including from 3 more countries!
Cerner Enviza's Auditron (Brazil) comprises of oncology patients with information regarding chemotherapy, target therapy, and radiotherapy claims since 2003. Auditron is fed by the private health insurances with anonymized patients’ information regarding diagnosis (histology, staging and mutations), treatment (including chemotherapy / systemic regimens, treatment duration, doses, cycles), and epidemiology data.
Send them a link to our latest tri-fold brochure which (1) lists the reasons why they should consider subscribing to our resource, (2) a summary of what’s included as part of their special access, (3) a complete list of the 45 countries we have database profiles and registries from, (4) along wit
We just updated the 10 IQVIA Oncology Dynamics database profiles in our resource (China, France, Germany, Italy, Japan, Mexico, Saudi Arabia, South Korea, Spain, and UK.) In the process, we uploaded 4 new ones from Belgium, Brazil, Bulgaria, and Romania.
Does your company routinely use population healthcare databases? There are hundreds available and deciding on the correct one for your needs may be difficult. Subscribe to B.R.I.D.G.E.
The IBM® MarketScan® Dental Database is a patient-level linked dental and medical insurance claims database that contains ~28.6 million covered lives. Established in 2005, this database is used for longitudinal and comparative analyses of diseases, treatment patterns, costs, duration of therapy, concomitant therapies, and other research purposes.
ADOReg is a nationwide German prospective registry for health services research in dermatologic oncology. The skin cancer registry ADOReg was developed by ADO and ONKODATAMED GmbH working in collaboration - in 2014. The data come from skin cancer treating sites (59 as of 2021) which treat ~8,500 patients, who have one of the following types of skin cancer:
- Malignant Melanoma
The Tempus N & ASCO/CancerLinQ® is a longitudinal population database covering over 25% of all cancer patients in the US and utilizes electronic medical records for Biological Modeling, Next-generation sequencing (NGS)/Pathology, Real World Data Aggregation & Analytics (standard and bespoke); and Technology applications (Custom and Machine Learning) embedded into its platform.
Have you ever wanted to try our nonprofit resource, www.bridgetodata.org, to conduct a search and find the right database or registry for your project or research work? If so, this would be a great time, because new users get 10% off – but only through the end of September.